BIVI - CIK 0001580149
The table below shows BIOVIE INC.'s income statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q4 2025 | Q3 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - |
| Cost of revenue | - | - | - | - | - | - |
| Gross profit | - | - | - | - | - | - |
| R&D | $3.18M | $4.27M | $2.94M | $1.34M | $4.70M | $1.99M |
| SG&A |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $2.15M |
| $1.94M |
| $2.29M |
| $1.59M |
| $2.53M |
| $2.07M |
| Operating income | -$5.39M | -$6.26M | -$5.28M | -$2.99M | -$7.29M | -$4.12M |
| Income tax | - | - | - | - | - | - |
| Net income | -$5.27M | -$6.07M | -$5.09M | -$2.79M | -$7.11M | -$4.15M |
| EPS (diluted) | -$0.70 | -$0.77 | -$0.98 | -$1.51 | -$4.55 | -$7.00 |